Abbott Laboratories (ABT) Asset Utilization Ratio (2009 - 2026)
Abbott Laboratories (ABT) reported Asset Utilization Ratio of 0.46 for Q1 2026, down 11.95% on a YoY basis from 0.52 in Q1 2025, and down 11.74% sequentially from 0.52 in Q4 2025.
Abbott Laboratories (ABT) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Abbott Laboratories (ABT) has 18 years of Asset Utilization Ratio data on file, last reported at 0.46 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 11.95% year-over-year to 0.46; the trailing twelve-month figure through Mar 2026 stood at 0.46 (down 11.95% YoY), and the FY2025 full-year result was 0.53, down 2.82% from the prior year.
- Asset Utilization Ratio retreated to 0.46 in Q1 2026, from 0.52 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.09 in Q1 2022 to a low of 0.46 in Q1 2026.
- A 5-year average of 0.64 and a median of 0.55 in 2023 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio gained 11.56% in 2022 and sank 48.92% in 2023, its largest moves.
- Tracing ABT's Asset Utilization Ratio over 5 years: stood at 1.08 in 2022, then slumped by 48.92% to 0.55 in 2023, then dropped by 2.44% to 0.54 in 2024, then fell by 3.68% to 0.52 in 2025, then retreated by 11.74% to 0.46 in 2026.
- Business Quant data shows ABT's Asset Utilization Ratio at 0.46 in Q1 2026, 0.52 in Q4 2025, and 0.52 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.46 |
| Dec 31, 2025 | 0.52 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | 0.54 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.56 |
| Mar 31, 2024 | 0.55 |
| Dec 31, 2023 | 0.55 |
| Sep 30, 2023 | 0.55 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 1.02 |
| Dec 31, 2022 | 1.08 |
| Sep 30, 2022 | 0.61 |
| Jun 30, 2022 | 0.61 |
| Mar 31, 2022 | 1.09 |
| Dec 31, 2021 | 1.06 |
| Sep 30, 2021 | 0.58 |
| Jun 30, 2021 | 0.55 |